News Column

Covidien Gets CE Mark of Nellcor Respiration Rate Technology

June 10, 2014

Covidien has reported the European commercial launch of its Nellcor Respiration Rate System.

In addition to the Adult Respiratory Sensor, the system includes the Nellcor Respiration Rate Version 2.0 software and Nellcor Bedside Respiratory Patient Monitoring System, PM1000N, both of which recently received CE Mark approval, the Company noted in its release.

With this addition to the Nellcor Respiratory Function portfolio - a single-sensor, pleth-based respiration rate monitoring technology - Covidien said that clinicians now can monitor a patient's SpO2, pulse rate and respiration rate through a single integrated finger sensor.

"The methods we currently have available to monitor respiration rate are not always accurate, despite the fact that it is a critical vital sign," said Dr. Graham Douglas, Respiratory Unit, Aberdeen Royal Infirmary. "The Respiration Rate system from Covidien gives us a better picture of a patient's overall respiratory status, does not change the workflow of our clinical staff and allows us to better provide effective treatment through a finger sensor that is familiar to clinicians and comfortable for patients."

"This single integrated sensor technology is a significant development in the patient monitoring industry," said Matt Anderson, vice president and general manager, Patient Monitoring, Covidien. "It supports Covidien's goal of being on the forefront of cutting- edge medical technology to enable clinicians to provide better patient care."

More Information:

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Health & Beauty Close - Up

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters